ACM
RMD icon

Accent Capital Management’s ResMed RMD Stock Holding History

Accent Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09K Buy
21
+5
+31% +$1.04K ﹤0.01% 291
2026
Q1 		$3.59K Sell
16
-2
-11% -$498 ﹤0.01% 301
2025
Q4 		$4.34K Hold
18
– – ﹤0.01% 311
2025
Q3 		$4.93K Buy
+18
New +$4.92K ﹤0.01% 325

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Accent Capital Management's RMD Position: Q2 2026 in Review

Accent Capital Management increased its ResMed (RMD) stake by 31% in Q2 2026, buying an estimated $1.04K and bringing the position to 21 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #291.

Accent Capital Management first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.93K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Accent Capital Management held 21 shares of ResMed worth $4.09K as of Q2 2026.
  • Accent Capital Management bought 5 ResMed shares in Q2 2026, an estimated $1.04K.
  • ResMed made up ﹤0.01% of Accent Capital Management's portfolio in Q2 2026, its #291 holding.
  • Accent Capital Management first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • Accent Capital Management's ResMed position peaked at $4.93K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.